Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrob Agents Chemother
; 45(3): 966-8, 2001 Mar.
Article
em En
| MEDLINE
| ID: mdl-11181393
ABSTRACT
The synergism of voriconazole (VRC) and terbinafine was studied by using 39 genotypically defined clinical Candida albicans isolates that were cross-resistant to fluconazole and VRC and serial isolates that gradually developed azole resistance. Synergy was noticed in 100% (eight of eight) of the strains that were resistant to VRC. Antagonism was not observed.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirimidinas
/
Triazóis
/
Candida albicans
/
Infecções por HIV
/
Antifúngicos
/
Naftalenos
Limite:
Humans
Idioma:
En
Ano de publicação:
2001
Tipo de documento:
Article